Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 424,966,351
- Total 13F shares
- 316,171,106
- Share change
- +5,297,167
- Total reported value
- $8,334,967,211
- Put/Call ratio
- 46%
- Price per share
- $26.37
- Number of holders
- 373
- Value change
- +$126,311,822
- Number of buys
- 192
- Number of sells
- 182
Quarterly Holders Quick Answers
What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G7709Q104:
Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
10%
|
44,217,888
|
$1,342,897,348 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.9%
|
37,699,682
|
$1,144,939,343 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
7.9%
|
33,634,216
|
$1,021,471,141 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5%
|
21,205,841
|
$644,021,397 | — | 31 Mar 2024 | |
| GG 1978 SICAF SIF S.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,081,156
|
$608,282,853 | — | 14 Sep 2022 | |
| GG 1978 SICAF SIF S.A. - GG Strategic |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
21,426,170
|
$590,239,561 | — | 20 Sep 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.9%
|
16,662,792
|
$506,048,992 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.7%
|
11,485,547
|
$348,816,062 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.5%
|
10,816,931
|
$328,510,194 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
9,100,148
|
$276,371,495 | — | 31 Mar 2024 | |
| Swedbank AB |
13F
|
Company |
1.9%
|
8,279,900
|
$251,461,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.9%
|
7,995,099
|
$242,811,157 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
6,548,054
|
$198,553,624 | — | 31 Mar 2024 | |
| Establishment Unisphere |
13F
|
Individual |
1.2%
|
5,000,000
|
$151,850,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
4,667,146
|
$141,741,224 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
4,500,061
|
$136,666,853 | — | 31 Mar 2024 | |
| Siguler Guff Advisers, LLC |
13F
|
Company |
0.8%
|
3,391,754
|
$103,007,569 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.76%
|
3,214,778
|
$97,632,808 | — | 31 Mar 2024 | |
| Mario Germano Giuliani |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,485,267
|
$96,010,741 | — | 23 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
2,813,133
|
$85,434,849 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.56%
|
2,368,804
|
$71,940,736 | — | 31 Mar 2024 | |
| William E. Ford |
3/4/5
|
Director |
—
class O/S missing
|
2,586,134
|
$71,241,786 | — | 30 Jun 2021 | |
| Avara Management Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,485,267
|
$68,463,141 | — | 29 Dec 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
2,250,361
|
$68,343,464 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.5%
|
2,134,904
|
$64,837,034 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.52%
|
2,208,455
|
$61,593,810 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.45%
|
1,903,242
|
$57,801,448 | — | 31 Mar 2024 | |
| HOMESTEAD ADVISERS CORP |
13F
|
Company |
0.45%
|
1,892,540
|
$57,502,359 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.44%
|
1,863,723
|
$56,601,265 | — | 31 Mar 2024 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.44%
|
1,856,998
|
$56,396,372 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.44%
|
1,852,660
|
$56,266,175 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
1,833,005
|
$55,668,361 | — | 31 Mar 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.43%
|
1,809,900
|
$54,966,663 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.36%
|
1,522,400
|
$46,235,288 | — | 31 Mar 2024 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Individual |
0.35%
|
1,500,000
|
$45,555,000 | — | 31 Mar 2024 | |
| NEW SOUTH CAPITAL MANAGEMENT INC |
13F
|
Company |
0.34%
|
1,461,455
|
$44,384,388 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
1,455,900
|
$44,215,683 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
1,446,846
|
$43,940,716 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.34%
|
1,444,516
|
$43,869,951 | — | 31 Mar 2024 | |
| Patient Capital Management, LLC |
13F
|
Company |
0.33%
|
1,419,818
|
$43,119,875 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.31%
|
1,303,659
|
$39,592,124 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.31%
|
1,298,400
|
$39,432,408 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.29%
|
1,225,373
|
$37,214,578 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.27%
|
1,151,771
|
$34,979,285 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
1,137,000
|
$34,530,690 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.23%
|
994,993
|
$30,217,938 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
977,706
|
$29,692,931 | — | 31 Mar 2024 | |
| Regal Partners Ltd |
13F
|
Company |
0.23%
|
959,827
|
$29,150,000 | — | 31 Mar 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.22%
|
931,360
|
$28,285,403 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.22%
|
924,433
|
$28,075,030 | — | 31 Mar 2024 |
Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q2 2024
As of 30 Jun 2024,
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by
373 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
316,171,106 shares.
The largest 10 holders included
MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., BAILLIE GIFFORD & CO, VIKING GLOBAL INVESTORS LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Swedbank AB, STATE STREET CORP, and JPMORGAN CHASE & CO.
This page lists
374
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
375
Q2 2024 holders
373
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.